Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the A Randomized, Double-Blind, Phase Iii, Non-Inferiority Clinical Trial Comparing the Efficacy and Safety of Ta4415v (A Proposed Trastuzumab Biosimilar) and Herceptin (Trastuzumab Reference Product) in Her2-Positive Early-Stage Breast Cancer Patients
Somayyeh Moradpanah
Somayyeh Moradpanah

Assistant Professor of Obstetrics and Gynecology

Department Obstetrics and Gynecology

School of Medicine

Ziaeian Hospital

Tehran University of Medical Sciences

All Documents